Conbercept in Choroidal Neovascularization Secondary to Uveitis

NCT02934841 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Choroidal Neovascularization
Uveitis

Interventions

DRUG: Conbercept
DRUG: sham

Sponsor

Chongqing Medical University